Search results for "Potency"

showing 2 items of 122 documents

MYOCARDIAL POTENCY OF AQUEOUS EXTRACT OF HARUNGANA MADAGASCARIENSIS STEM BARK AGAINST ISOPROTERENOL-INDUCED MYOCARDIAL DAMAGE IN RATS

2018

Objectives: The present study was undertaken to evaluate the effects of Harungana madagascariensis on electrocardiographical, biochemical and histopathological changes in isoproterenol (ISO)-induced myocardial infarction in rats. Methods: Male Wistar albino rats were randomly divided and treated with the aqueous extract of Harungana madagascariensis stem bark (AEHM, 200 and 400 mg/kg per os), or normal saline or vitamin E for 7 days with concomitant administration of ISO (85 mg/kg, subcutaneously) on 8th and 9th days, at 24 h interval. Results: The ISO injections to the rats caused cardiac dysfunction evidenced by a marked (P<0.01) elevation in ST-segment, a reduction in R wave amplitude (P…

medicine.medical_treatmentCardiac marker01 natural sciencesLipid peroxidation03 medical and health scienceschemistry.chemical_compound0302 clinical medicineLactate dehydrogenasemedicineHarungana[CHIM]Chemical SciencesPotencyComputingMilieux_MISCELLANEOUSbiologyTraditional medicinebusiness.industryVitamin E[SDV.SP]Life Sciences [q-bio]/Pharmaceutical sciencesMalondialdehydebiology.organism_classification030205 complementary & alternative medicine0104 chemical sciences3. Good health010404 medicinal & biomolecular chemistrychemistryFlacourtia indicabusinessUniversal Journal of Pharmaceutical Research
researchProduct

Antitumor Effect of Cabozantinib in Bone Metastatic Models of Renal Cell Carcinoma

2021

Background: The presence of bone metastases in renal cell carcinoma (RCC) negatively affects patients’ survival. Data from clinical trials has highlighted a significant benefit of cabozantinib in bone metastatic RCC patients. Here, we evaluated the antitumor effect of cabozantinib in coculture models of renal cell carcinoma (RCC) and osteoblasts (OBs) to investigate whether and how its antiproliferative activity is influenced by OBs. Methods: Bone/RCC models were generated, coculturing green fluorescent protein (GFP)-tagged Caki-1 and 786-O cells with human primary OBs in a “cell–cell contact” system. RCC proliferation and the OB molecular profile were evaluated after the cabozantinib treat…

renal cell carcinomaCabozantinibQH301-705.5Biologyurologic and male genital diseasesGeneral Biochemistry Genetics and Molecular BiologyArticleGreen fluorescent proteinchemistry.chemical_compoundCabozantinib; Osteoblasts; Renal cell carcinomaRenal cell carcinomacabozantinibmedicineBiology (General)Antitumor activityGeneral Immunology and MicrobiologyCell growthOsteoblastosteoblastsmedicine.diseasefemale genital diseases and pregnancy complicationsInhibitory potencychemistryCancer researchMolecular ProfileGeneral Agricultural and Biological SciencesBiology
researchProduct